Related Experiment Videos
[Gene therapy and ethics]
1Abteilung Medizinische Genetik, Universitätskinderklinik, Basel.
Schweizerische Medizinische Wochenschrift
|January 10, 1995
Summary
Gene therapy offers a novel approach to treating genetic and acquired diseases like cancer and viral infections. While somatic gene therapy is widely accepted, germ-line gene therapy faces significant ethical and practical objections.
Area of Science:
- Biomedical Ethics
- Molecular Biology
- Medical Genetics
Context:
- Gene therapy, initially proposed for monogenetic disorders, has expanded to address acquired diseases.
- Applications now include cancer and viral infections like HIV and Hepatitis B.
- The ethical landscape of gene therapy is complex and evolving.
Purpose:
- To review the practical and ethical considerations of gene therapy.
- To summarize viewpoints presented at the 1994 Swiss Society for Biomedical Ethics meeting.
- To differentiate between somatic and germ-line gene therapy implications.
Summary:
- Somatic gene therapy, which affects non-reproductive cells, has gained broad approval due to fewer ethical concerns.
- Germ-line gene therapy, affecting reproductive cells, is largely opposed by ethical bodies.
- Fundamental and pragmatic concerns lead to calls for banning medical applications of germ-line gene therapy.
Impact:
- Highlights the critical ethical debate surrounding germ-line gene therapy.
- Informs ongoing discussions on the responsible development and application of gene therapy.
- Underscores the distinction between therapeutic approaches with differing ethical ramifications.